Introduction 7.33265
:Ċ 5.6186147
Mel 9.735193
an 1.8282423
oma 0.38564903
, 2.881822
Ġa 1.5743623
Ġform 2.2283893
Ġof 0.003550774
Ġskin 0.12193026
Ġcancer 0.005747945
, 0.24348457
Ġhas 3.139317
Ġexperienced 5.6054497
Ġsignificant 3.057877
Ġadvancements 5.376469
Ġin 0.13312708
Ġtreatments 3.8360047
Ġin 1.7966937
Ġrecent 0.53270954
Ġyears 0.038089346
. 0.43088868
ĠAmong 5.891074
Ġthese 0.89616483
Ġadvancements 1.352773
, 1.4317156
Ġimmune 4.1274333
Ġcheckpoint 0.33277613
Ġinhibitors 0.21063204
Ġand 3.3495917
Ġad 6.795566
ju 0.01042807
vant 0.0067295767
Ġtherapies 1.1570848
Ġhave 0.54248774
Ġemerged 2.9595447
Ġas 0.13011381
Ġpromising 2.0929947
Ġapproaches 3.6336694
. 2.1535366
ĠThis 3.0143557
Ġessay 6.608178
Ġexplores 3.0885358
Ġthe 0.5027252
Ġpotential 3.6048517
Ġbenefits 2.687758
Ġof 0.9430381
Ġthese 1.8237375
Ġtreatments 1.5621907
, 1.5202919
Ġtheir 3.0959556
Ġimplications 4.2502785
Ġfor 0.6878361
Ġpatients 2.220158
Ġat 6.7375107
Ġdifferent 2.1396127
Ġstages 0.21185392
Ġof 0.12745495
Ġmelan 0.9182667
oma 0.00087394373
, 0.2759297
Ġand 0.20856422
Ġtheir 1.8042686
Ġimpact 2.8016958
Ġon 0.04006176
Ġimproving 7.069226
Ġsurvival 3.2440596
Ġrates 0.6119644
. 1.5345781
ĠFurthermore 3.7992344
, 0.004431778
Ġit 1.4056374
Ġwill 2.2673178
Ġdraw 6.5915985
Ġon 1.9446987
Ġresearch 3.213171
Ġevidence 4.752369
Ġand 1.8534179
Ġanalyze 4.807728
Ġthe 0.77130336
Ġcase 5.9243345
Ġof 0.9612632
ĠMr 5.499211
. 0.055153295
ĠB 3.7814476
Ġas 4.9781723
Ġan 1.0420601
Ġillustr 3.2249832
ative 0.0010544842
Ġexample 0.10145512
.Ċ 1.3903307
Body 5.708674
:Ċ 0.21817896
I 3.3206756
. 0.07347979
ĠImm 1.6485423
une 0.009512165
ĠCheck 1.1464792
point 0.015113869
ĠIn 0.048384763
hib 0.008441645
itors 0.028964946
:Ċ 1.9658422
A 1.5349464
. 0.076740466
ĠMechan 3.1592293
ism 0.0842511
Ġof 0.42632762
ĠAction 0.44981545
:Ċ 0.84374934
Imm 1.2462183
une 0.0013045222
Ġcheckpoint 0.07153048
Ġinhibitors 0.03755123
, 2.4769635
Ġsuch 1.5853097
Ġas 0.0018987674
Ġpemb 1.9778738
rol 0.00065405876
iz 0.0059160003
um 0.0014336822
ab 0.00012248923
Ġand 1.0334647
Ġn 0.39245895
iv 0.0017157549
olum 0.0015545015
ab 0.0010528154
, 0.057812016
Ġaim 5.1881013
Ġto 0.052833647
Ġenhance 2.6622307
Ġthe 0.36720058
Ġbody 1.1987239
's 2.826174
Ġimmune 0.6563673
Ġresponse 0.6420869
Ġagainst 1.2520212
Ġmelan 1.7771785
oma 0.008231569
Ġcells 1.531953
Ġby 1.170026
Ġblocking 0.8082906
Ġthe 1.0045426
Ġsuppress 6.409145
ive 0.12364316
Ġsignals 1.8271534
Ġimposed 9.632834
Ġby 0.18161342
Ġspecific 5.046434
Ġimmune 1.812958
Ġcheckpoints 0.7328503
, 1.7874507
Ġlike 4.9717345
ĠPD 0.75118697
- 0.17587614
1 0.0017276569
/P 3.1162071
D 0.05711206
-L 0.013013744
1 0.013455849
Ġand 1.6587071
ĠCTL 0.00916057
A 0.012071495
- 0.06768218
4 0.0014259486
.Ċ 2.3243322
B 1.2208831
. 0.0033629546
ĠEffect 4.9235234
iveness 0.06896712
Ġand 2.4592109
ĠLong 5.0981503
-term 1.1838365
ĠRem 7.4517984
ission 0.1660894
:Ċ 0.18398023
Research 3.391094
Ġhas 1.2687174
Ġshown 0.49884656
Ġsubstantial 8.63778
Ġpromise 3.7182481
Ġin 1.0310215
Ġimmune 2.0597467
Ġcheckpoint 0.019138655
Ġinhibitors 0.20331538
, 1.5530536
Ġleading 5.0120087
Ġto 0.16927288
Ġimpressive 5.129122
Ġresponse 2.7115521
Ġrates 0.09870665
Ġand 1.0542076
Ġdurable 2.108334
, 3.42699
Ġlong 0.14137736
-term 0.07990413
Ġrem 0.2306436
ission 1.1338925
Ġin 1.327453
Ġpatients 1.2185677
Ġwith 0.53824276
Ġadvanced 0.9480937
Ġmelan 0.26287085
oma 0.007530913
. 0.61924535
ĠClinical 5.4158325
Ġtrials 0.24782044
Ġdemonstrated 3.801723
Ġa 2.079184
Ġsignificant 3.1540174
Ġsurvival 2.4617438
Ġadvantage 1.2681434
Ġfor 1.5032334
Ġpatients 0.69597757
Ġtreated 1.0862175
Ġwith 0.016245855
Ġpemb 2.2783508
rol 0.00015478976
iz 0.0010453128
um 0.0008093867
ab 4.692145e-05
Ġand 1.5194509
Ġn 0.06480402
iv 0.0009587471
olum 0.0012263007
ab 0.0013807098
Ġcompared 1.3463439
Ġto 0.17280674
Ġtraditional 3.856793
Ġtherapies 1.5217867
.Ċ 2.4257197
C 1.137264
. 0.0032492469
ĠImp 3.3442345
lications 0.05476401
Ġfor 0.51616585
ĠPatients 0.9185206
Ġat 1.2587802
ĠDifferent 0.09448423
ĠSt 0.028800962
ages 0.0002969704
:Ċ 1.1074398
1 2.0932324
. 0.0509222
ĠAdvanced 3.0493808
ĠMel 1.1109565
an 0.000106046464
oma 0.0031414742
: 1.1736398
ĠImm 1.8033712
une 0.00082046894
Ġcheckpoint 0.015953664
Ġinhibitors 0.024736147
Ġhave 1.1475363
Ġproven 2.5092893
Ġparticularly 4.0245075
Ġeffective 0.39426246
Ġin 0.6593284
Ġpatients 1.2100824
Ġwith 0.06530947
Ġadvanced 0.2681526
Ġor 4.565227
Ġmetast 0.26517043
atic 0.010158454
Ġmelan 0.05184589
oma 0.008230742
, 1.1855555
Ġachieving 4.3237963
Ġhigher 4.1809425
Ġresponse 0.20304732
Ġrates 0.035332914
Ġand 0.5638552
Ġsuperior 5.478142
Ġoverall 2.4837937
Ġsurvival 0.05271106
Ġcompared 1.0495975
Ġto 0.04571068
Ġstandard 2.9181504
Ġtreatments 1.9449596
.Ċ 0.80456096
2 0.1866435
. 0.0019424419
ĠEarly 1.5382522
-stage 2.0050647
ĠMel 0.15975755
an 2.7610455e-05
oma 0.00439546
: 0.07353229
ĠStudies 4.5565686
Ġare 2.4878783
Ġunderway 1.6405982
Ġto 0.15170988
Ġinvestigate 2.347291
Ġthe 0.29422215
Ġpotential 1.639551
Ġrole 2.7226624
Ġof 0.045576517
Ġimmune 0.3251817
Ġcheckpoint 0.009433638
Ġinhibitors 0.018067997
Ġin 0.30531597
Ġad 3.291206
ju 1.9862217e-05
vant 0.0019785953
Ġtherapy 0.58064485
Ġsettings 4.909576
, 1.4974195
Ġwhich 2.7128115
Ġmay 1.7050058
Ġimprove 2.4483979
Ġoutcomes 1.6690999
Ġand 2.3212419
Ġreduce 1.4391695
Ġrecurrence 1.2235008
Ġrates 1.0391258
Ġin 0.82865095
Ġpatients 0.5867085
Ġwith 0.17628098
Ġearlier 4.549881
Ġstages 1.2859075
Ġof 0.038836
Ġmelan 0.13450135
oma 0.0008020034
.Ċ 0.19668359
II 1.4633261
. 0.0050234753
ĠAd 0.1130952
ju 7.922564e-05
vant 0.00018292182
ĠTher 1.132406
ap 0.00074554485
ies 0.0001558626
:Ċ 0.18374665
A 0.047932394
. 0.0015148617
ĠCombination 3.877252
ĠTher 2.4962106
ap 0.0018587958
ies 3.6789137e-05
:Ċ 0.31937155
Com 4.64563
binations 0.2177261
Ġof 0.06382793
Ġimmune 1.6051861
Ġcheckpoint 0.014032337
Ġinhibitors 0.018513126
Ġwith 1.1663702
Ġother 0.65812296
Ġad 2.5647671
ju 8.42322e-05
vant 0.0013240495
Ġtherapies 0.1778769
, 0.7190562
Ġsuch 0.35015494
Ġas 0.00358273
Ġtargeted 2.1519377
Ġtherapies 0.3417
Ġor 2.0161042
Ġradio 2.7265422
therapy 0.03531289
, 0.030949406
Ġshow 4.0951195
Ġpotential 2.1793225
Ġin 1.2371706
Ġimproving 0.8834472
Ġtreatment 3.3706002
Ġoutcomes 0.41984925
Ġand 1.4968462
Ġpreventing 3.5250607
Ġtumor 3.73113
Ġrel 2.1813643
apse 0.06602404
.Ċ 0.8286636
B 0.074181326
. 0.0007811574
ĠEffect 4.1674423
iveness 0.02133141
Ġin 2.4818356
ĠRed 2.7924879
ucing 0.0002609782
ĠRec 0.54556423
urrence 0.028784746
:Ċ 0.8970788
Clinical 2.373657
Ġtrials 0.27850467
Ġhave 0.5451667
Ġillustrated 6.702505
Ġthe 0.88525385
Ġeffectiveness 1.5949602
Ġof 0.028113186
Ġad 0.9578573
ju 3.8577193e-05
vant 0.0003976608
Ġtherapies 0.50694144
Ġin 0.2211512
Ġsignificantly 4.2683215
Ġreducing 0.118025534
Ġthe 1.2040321
Ġrisk 0.46421206
Ġof 0.01623847
Ġrecurrence 0.7958102
Ġin 1.1464195
Ġpatients 0.29011774
Ġwith 0.15566683
Ġhigh 2.5299327
-risk 0.09366098
Ġmelan 0.54898846
omas 4.157535
Ġafter 4.334489
Ġsurgical 1.3972135
Ġremoval 1.3834127
.Ċ 0.96710813
C 0.56278145
. 0.0013377434
ĠImp 1.072994
lications 0.0145474
Ġfor 0.065921806
ĠPatients 0.25403288
Ġat 0.2183622
ĠDifferent 0.01975713
ĠSt 0.003692478
ages 8.061054e-06
:Ċ 0.040634587
1 0.14790952
. 0.0012169019
ĠIntermediate 5.4228764
Ġto 3.803614
ĠHigh 0.112964466
-risk 0.2485522
ĠMel 0.62509775
an 6.408677e-05
oma 0.11325787
: 0.12359439
ĠAd 0.81934154
ju 4.0961266e-05
vant 7.076218e-05
Ġtherapies 0.28521395
Ġhave 1.2720896
Ġshown 1.315227
Ġpromising 1.8559166
Ġresults 0.4035453
Ġin 0.12693892
Ġimproving 2.1643546
Ġsurvival 1.3640152
Ġrates 0.8594072
Ġand 0.6763526
Ġprolong 5.854293
ing 0.003215261
Ġrem 1.982782
ission 0.09107315
Ġin 0.37616304
Ġpatients 0.19073547
Ġat 2.9556057
Ġintermediate 0.30822617
Ġto 0.17978925
Ġhigh 0.0065166564
-risk 0.7691873
Ġstages 1.8801546
Ġof 0.3869032
Ġmelan 0.016775966
oma 0.0029968394
, 2.027402
Ġreducing 3.1997185
Ġthe 0.56770885
Ġchances 4.0582967
Ġof 0.01908848
Ġrecurrence 0.68656033
Ġand 1.3007649
Ġdisease 2.947402
Ġprogression 0.09332876
.Ċ 0.16471964
2 0.08869285
. 0.00088109233
ĠLow 0.33945563
-risk 0.048935242
ĠMel 0.016102647
an 0.00013524403
oma 0.006457313
: 0.019218652
ĠThe 2.873316
Ġrole 1.8741497
Ġof 0.020761078
Ġad 0.017091129
ju 1.1398757e-05
vant 0.0002040172
Ġtherapies 0.18295793
Ġin 0.3838167
Ġlow 1.0044789
-risk 0.014699652
Ġmelan 0.19484416
oma 0.30929676
Ġis 0.88550067
Ġnot 2.4278502
Ġyet 0.991077
Ġwell 1.8484986
-established 1.578261
. 1.1242435
ĠMore 2.9613006
Ġresearch 0.50289387
Ġis 0.12286626
Ġneeded 0.28912446
Ġto 0.09717547
Ġdetermine 1.0599211
Ġtheir 2.042022
Ġpotential 1.8348916
Ġbenefits 1.0103508
Ġin 0.9986221
Ġthis 0.7143473
Ġpatient 1.5774838
Ġpopulation 0.19919214
.Ċ 0.09708157
III 0.64683646
. 0.0024060968
ĠImp 3.0022812
lications 0.0635597
Ġfor 0.5361416
ĠSurvival 3.6000733
ĠRates 0.40227845
Ġand 2.5990775
ĠMr 5.528994
. 0.007913344
ĠB 0.0030560233
's 1.6946877
ĠCase 0.34284166
:Ċ 0.07603906
A 0.7126451
. 0.0047671227
ĠImpact 3.399882
Ġon 0.532901
ĠSurvival 0.27077922
ĠRates 0.11592256
:Ċ 0.33752775
The 2.1302912
Ġintroduction 3.2519782
Ġof 0.05288317
Ġimmune 0.5926031
Ġcheckpoint 0.0049849283
Ġinhibitors 0.007181453
Ġand 0.15959091
Ġad 0.061037734
ju 9.014684e-06
vant 0.0004776208
Ġtherapies 0.03740562
Ġhas 0.5806661
Ġsignificantly 1.6800883
Ġenhanced 3.6478624
Ġsurvival 1.8158659
Ġrates 0.16577068
Ġin 1.0323489
Ġpatients 0.4881072
Ġwith 0.054875508
Ġadvanced 0.7153317
Ġmelan 0.2660517
oma 0.026655087
. 0.9362122
ĠThese 3.1189888
Ġtreatments 0.70177966
Ġoffer 3.7566905
Ġnew 3.2568214
Ġhope 1.0541539
Ġfor 0.7414561
Ġlong 3.7965395
-term 0.10027945
Ġrem 0.38857132
ission 0.039051905
.Ċ 3.5960846
B 0.05664244
. 0.0007071906
ĠMr 1.5036978
. 0.003165599
ĠB 0.0010310231
's 0.15130828
ĠCase 0.20563424
:Ċ 0.28421715
Mr 0.80255824
. 0.003901246
ĠB 0.0031077263
, 1.4334972
Ġdiagnosed 4.0083227
Ġwith 0.069161594
Ġadvanced 2.2201755
Ġmelan 0.2501456
oma 0.00010640408
, 0.5602653
Ġexempl 6.9934473
ifies 0.0054608323
Ġthe 0.14307745
Ġpotential 1.1734501
Ġof 2.666577
Ġimmune 1.0346003
Ġcheckpoint 0.008544837
Ġinhibitors 0.019260855
Ġto 3.4490845
Ġachieve 3.1297781
Ġrem 3.6752782
ission 0.022000082
. 1.5652078
ĠWith 4.003114
Ġpemb 2.688386
rol 9.7583004e-05
iz 0.0006534627
um 0.00032700237
ab 1.7239736e-05
Ġtreatment 1.7044055
, 0.07545568
Ġhis 1.8081625
Ġtumor 1.5370957
Ġshr 2.2661424
inks 5.6144466
Ġsignificantly 1.4494045
, 0.89489096
Ġleading 2.510526
Ġto 0.04255272
Ġincreased 5.034333
Ġoverall 2.679178
Ġsurvival 0.050667934
Ġand 1.0920666
Ġquality 2.8856525
Ġof 0.013125406
Ġlife 0.0013535682
.Ċ 0.37750047
Conclusion 0.21046494
:Ċ 0.10665673
The 1.719235
Ġadvancements 3.738326
Ġin 0.3150156
Ġimmune 1.4228064
Ġcheckpoint 0.016053723
Ġinhibitors 0.04359611
Ġand 0.02366038
Ġad 0.010044574
ju 7.58424e-06
vant 0.00020222914
Ġtherapies 0.031943653
Ġhave 0.53799003
Ġrevolution 2.964343
ized 0.0012691627
Ġmelan 1.623188
oma 0.00010926496
Ġtreatment 0.21801995
, 1.0894002
Ġoffering 1.7129066
Ġimproved 3.8010015
Ġsurvival 0.82336056
Ġrates 0.1614505
Ġand 0.33385846
Ġthe 4.441126
Ġpotential 0.5588775
Ġfor 0.18110907
Ġlong 0.156983
-term 0.23937331
Ġrem 0.028113538
ission 0.027123684
. 0.55646974
ĠThese 2.0540624
Ġtreatments 0.98982644
Ġhave 1.5559213
Ġshown 3.3647401
Ġparticular 2.5411549
Ġefficacy 3.554981
Ġin 0.09402739
Ġpatients 0.6572453
Ġwith 0.11608315
Ġadvanced 0.086859465
Ġmelan 0.24467699
oma 0.03722647
, 0.74178475
Ġwhile 3.2009087
Ġongoing 3.2999666
Ġresearch 0.45856643
Ġexplores 3.62778
Ġtheir 0.21797632
Ġbenefits 3.1493173
Ġfor 2.4745152
Ġpatients 0.7748665
Ġat 0.47609484
Ġearlier 0.5153343
Ġstages 0.019509781
. 0.91767967
ĠThe 2.4423044
Ġcase 0.8230941
Ġof 0.040068403
ĠMr 0.0041917753
. 0.016113548
ĠB 0.0005176476
Ġfurther 4.44518
Ġdemonstrates 1.9995017
Ġthe 0.2591873
Ġprofound 6.4112377
Ġimpact 0.5234243
Ġthese 1.8639504
Ġtherapies 2.1588602
Ġcan 0.44994307
Ġhave 0.030543841
Ġon 0.47009572
Ġpatients 1.2409204
' 0.7568888
Ġlives 0.6098293
, 2.0005052
Ġinspiring 5.439043
Ġhope 0.24228269
Ġfor 0.56523156
Ġa 1.7590754
Ġbrighter 1.540792
Ġfuture 0.06730242
Ġin 2.696978
Ġmelan 0.7681799
oma 6.396757e-05
Ġmanagement 3.4163494
. 0.8749867
